What Are The Chances Of Ngm Biopharmaceuticals Inc (NASDAQ: NGM) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. The stock was recently discussed on Yahoo Finance as it revealed that NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

As a NASDAQ listed company, NGM falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Ngm Biopharmaceuticals Inc is $125.73M. A total of 0.53 million shares were traded on the day, compared to an average of 0.53 shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, NGM has seen 6 BUY and 0 SELL insider trades, representing the acquisition of 49,442 and the disposition of 0 shares. Over the last 12 months, there were 11 BUYs and 0 SELLs from insiders. Insiders purchased 418,642 shares during that period but sold 0.

In the most recent transaction, COLUMN GROUP L P bought 5,840 shares of NGM for 0.62 per share on Nov 16. After the transaction, the Director now owns 949,862 company shares. In a previous transaction on Nov 16, COLUMN GROUP L P bought 5,840 shares at 0.62 per share. NGM shares that Director owns now total 949,862.

Among the insiders who bought shares, COLUMN GROUP L P acquired of 5,840 shares on Nov 16 at a per-share price of $0.62. This resulted in the Director holding 949,862 shares of NGM after the transaction. In another insider transaction, GOEDDEL DAVID V bought 5,840 shares at $0.62 per share on Nov 16. Company shares held by the Director now total 949,862.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for NGM in the last 3 months, the mean price target is $4.70 with high estimates of $6.00 and low estimates of $3.50. In terms of 52-week highs and lows, NGM has a high of $5.19 and a low of $0.60.

As of this writing, NGM has an earnings estimate of -$0.39 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.66. The company reported an EPS of -$0.46 in the last quarter, which was 8.00% higher than expectations of -$0.5.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NGM’s latest balance sheet shows that the firm has $366.25M in Cash & Short Term Investments as of fiscal 2021. There were $10.46M in debt and $61.35M in liabilities at the time. Its Book Value Per Share was $2.05, while its Total Shareholder’s Equity was $335.65M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NGM is Buy with a score of 4.17.

Most Popular

Related Posts